Zalevsky Jonathan sold NKTR
January 20, 2026 · Form 4 insider transaction
Zalevsky Jonathan sold 3,867 shares of Nektar Therapeutics at $35.67 per share, a transaction worth $137.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025.; This transaction was executed in multiple trades at prices ranging from $35.17 to $36.23 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.